Drug compounders on Monday sued the U.S. Food and Drug Administration over its decision last week to remove Novo Nordisk's ...
Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.
Investors in the Magnificent Seven stocks, take note. As Arnott wrote in an email: "Whoever coined the expression 'Magnificent Seven' for these companies presumably didn't see the movie, where four of ...
Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results